Bolden Nicholas C, Pavchinskiy Rebecca G, Melikian Haley E
Department of Neurobiology, UMASS Chan Medical School, Worcester, Massachusetts, USA.
Morningside Graduate School of Biomedical Sciences, UMASS Chan Medical School, Worcester, Massachusetts, USA.
J Neurochem. 2025 Jan;169(1):e16284. doi: 10.1111/jnc.16284.
The dopamine (DA) transporter (DAT) is a major determinant of DAergic neurotransmission, and is a primary target for addictive and therapeutic psychostimulants. Evidence accumulated over decades in cell lines and in vitro preparations revealed that DAT function is acutely regulated by membrane trafficking. Many of these findings have recently been validated in vivo and in situ, and several behavioral and physiological findings raise the possibility that regulated DAT trafficking may impact DA signaling and DA-dependent behaviors. Here we review key DAT trafficking findings across multiple systems, and discuss the cellular mechanisms that mediate DAT trafficking, as well as the endogenous receptors and signaling pathways that drive regulated DAT trafficking. We additionally discuss recent findings that DAT trafficking dysfunction correlates to perturbations in DA signaling and DA-dependent behaviors.
多巴胺(DA)转运体(DAT)是多巴胺能神经传递的主要决定因素,也是成瘾性和治疗性精神兴奋剂的主要作用靶点。数十年来在细胞系和体外制剂中积累的证据表明,DAT功能受到膜转运的急性调节。最近,其中许多发现已在体内和原位得到验证,一些行为和生理发现表明,受调节的DAT转运可能会影响多巴胺信号传导和多巴胺依赖行为。在这里,我们综述了多个系统中DAT转运的关键发现,并讨论了介导DAT转运的细胞机制,以及驱动受调节DAT转运的内源性受体和信号通路。我们还讨论了最近的发现,即DAT转运功能障碍与多巴胺信号传导和多巴胺依赖行为的紊乱有关。